Cargando…
Bioactive adrenomedullin for assessment of venous congestion in heart failure
AIMS: Bioactive adrenomedullin (bio‐ADM) is a vascular‐derived peptide hormone that has emerged as a promising biomarker for assessment of congestion in decompensated heart failure (HF). We aimed to evaluate diagnostic and prognostic performance of bio‐ADM for HF in comparison to amino‐terminal pro‐...
Autores principales: | Egerstedt, Anna, Czuba, Tomasz, Bronton, Kevin, Lejonberg, Carl, Ruge, Thoralph, Wessman, Torgny, Rådegran, Göran, Schulte, Janin, Hartmann, Oliver, Melander, Olle, Smith, J. Gustav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715871/ https://www.ncbi.nlm.nih.gov/pubmed/35903845 http://dx.doi.org/10.1002/ehf2.14018 |
Ejemplares similares
-
Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study
por: Bronton, Kevin, et al.
Publicado: (2021) -
Socioeconomic and Clinical Predictors of Mortality in Patients with Acute Dyspnea
por: Wessman, Torgny, et al.
Publicado: (2021) -
Associations between biomarkers of multimorbidity burden and mortality risk among patients with acute dyspnea
por: Wessman, Torgny, et al.
Publicado: (2021) -
Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care
por: Lundberg, Oscar H. M., et al.
Publicado: (2022) -
Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness
por: Lundberg, Oscar H. M., et al.
Publicado: (2020)